Periodoncia.Eley.6a.Ed

Posible uso de antibióticos como auxiliares en el tratamiento de la periodontitis crónica 269
© ELSEVIER. Fotocopiar sin autorización es un delito.
Listgarten MA, Lindhe J, Helldén L: Effect of tetracycline and/or scaling in human
periodontal disease, J Clin Periodontol 5:246–271, 1978.
Livermore DM: Beta-lactamases in clinical and laboratory resistance, Clin Infect Dis
15:824–839, 1992.
Livermore DM: Beta-lactamases in laboratory and clinical resistance, Clin Microbiol Rev
8:557–584, 1995.
Livermore DM: Acquired carbapenemases, J Antimicrob Chemother 39:673–676, 1997.
Livermore DM, Yuan M: Antibiotic resistance and production of
extended-spectrum-beta-lactamases among Klebsiella spp from intensive care units in
Europe, J Antimicrob Chemother 38:409–427, 1996.
Loesche WJ: Chemotherapy of dental plaque infections, Oral Science Review 9:65–107,
1976.
Loesche WJ, Syed SA, Morrison EC, et al: Metronidazole in periodontitis. I. Clinical and
bacteriological results after 15 to 30 weeks, J Periodontol 55:325–335, 1985.
Loesche WJ, Schmidt E, Smith BA, et al: Effects of metronidazole on periodontal
treatment needs, J Periodontol 62:247–257, 1991.
Loesche WJ, Giordano JR, Hujoel PP, et al: Metronidazole in periodontitis: Reduced
needs for surgery, J Clin Periodontol 19:103–112, 1992.
Loesche WJ, Grossman N, Giordano JR: Metronidazole in periodontitis. IV. The effect of
patient compliance on treatment parameters, J Clin Periodontol 20:96–104, 1993.
Lovejoy B, Cleasby A, Hassell A, et al: Structure of the catalytic domain of fibroblast
collagenase complexed with an inhibitor, Sci 263:375–377, 1994.
Magnusson I: The use of locally-delivered metronidazole in the treatment of periodontitis.
Clinical results, J Clin Periodontol 25:959–963, 1998.
Mandell GL, Petri WA: Antimicrobial agents: sulphonamides,
trimethoprim-sulfamethoxazole, quinolones and agents: for urinary tract infections.
In Goodman-Gilman A, Hardman JG, Limbird LE, Molinoff PB, Ruddon RE, editors:
Goodman y Gilman’s the pharmacological basis of therapeutics, ed 9, New York,
1996a, McGraw-Hill, pp 1057–1072, Ch. 44 Section IX, Chemotherapy of microbial
disease.
Mandell GL, Petri WA: Antimicrobial agents: penicillins, cephalosporins and other
beta-lactam antibiotics. In Goodman-Gilman A, Hardman JG, Limbird LE, Molinoff
PB, Ruddon RE, editors: Goodman y Gilman’s the pharmacological basis of
therapeutics, ed 9, New York, 1996b, McGraw-Hill, pp 1073–1102, Ch. 45 Section IX,
Chemotherapy of microbial disease.
Mandell RC, Tripodi LS, Savitt E, et al: The effect of treatment on Actinobacillus
actinomycetemcomitans in localized juvenile periodontitis, J Periodontol 57:94–99,
1986.
Manian FA, Meyer L, Jenne J, et al: Loss of antimicrobial susceptibility in aerobic
gram-negative bacilli repeatedly isolated from patients in intensive care units, Infect
Control Hosp Epidemiol 17:222–226, 1996.
Maples RR, Speller DC, Cookson BD: Prevalence of Mupirocin resistance in
Staphylococcus aureus, J Hosp Infect 29:153–155, 1995.
Martin MV, Longman LP, Hill JB, et al: Acute dentoalveolar infections: an investigation
of the duration of antibiotic therapy, Br Dent J 183:135–137, 1997.
L. Martinez-Martinez, 1997 ICAAC Abstract LB-20. ICAAC 1997 American Society for
Microbiology: Washington DC 12.
McCracken GH Jr: Emergence of resistant Streptococcus pneumoniae: a problem in
pediatrics, Pediatr Infect Dis J 14:211–215, 1995.
McGowen JE Jr, Gerding DN: Does antibiotic restriction prevent resistance? New Horiz
4:370–376, 1996.
Meyer BK: Comparative toxicities of the 3rd generation cephalosporins, Am J Med
79(Suppl 12):96–103, 1985.
Miller JF, Mekalananos JJ, Falkow S: Coordinate regulation and sensory transduction in
the control of bacterial virulence, Sci 243:916–922, 1989.
Mombelli A, Lehmann B, Tonetti M, et al: Clinical response to local delivery tetracycline
in relation to overall and local periodontal conditions, J Clin Periodontol 24:470–477,
1997.
Moore M, Onorato IM, McCray E, et al: Trends in drug-resistant tuberculosis in the
United States, 19931996, J Am Med Assoc 278:833–837, 1997.
Morrison SL, Cobb CM, Kazakos G, et al: Root surface characteristics associated with
subgingival placement of monolithic tetracycline-impregnated fibres, J Periodontol
63:137–143, 1992.
Muder RR, Brennen C, Drenning SD, et al: Multiple resistant gram-negative bacilli in a
long-term care facility; a case control study of patient risk factors and prior antibiotic
use, Infect Control Hosp Epidemiol 18:809–813, 1997.
Neidhardt FC, Ingraham JL, Low KB: Escherichia coli, Salmonella typhimurium: Cellular
and Molecular Biology, Washington DC, 1987, American Society for Microbiology.
Neu HC: Antimicrobial chemotherapy. In Baron S, Jennings PM, editors: Medical
Microbiology, ed 3, New York, 1991, Churchill Livingstone, pp 179–201, Ch. 11.
Newman MG, Kornman KS, Doherty FM: A 6-months multi-center evaluation of
adjunctive tetracycline fibre therapy in conjunction with scaling and root planing in
maintenance patients: clinical results, J Periodontol 65:685–691, 1994.
Nikaido H: Multidrug efflux pumps of gram-negative bacteria, J Bacteriol 178:5853–
5859, 1996.
Noache LA, Langenberg WL, Bertola MA, et al: Impact of metronidazole resistance on
the eradication of Helicobacter pylori, Scand J Infect Dis 26:321–327, 1994.
Noble WC, Howell SA: Labile antibiotic resistance in Staphylococcus aureus, J Hosp
Infect 31:135–141, 1995.
Noiri Y, Okami Y, Narimatsu M, et al: Effects of chlorhexidine, minocycline and
metronidazole on Porphyromonas gingivalis strain 381 in biofilms, J Periodontol
74:1647–1651, 2003.
Norling T, Lading P, Engström S, et al: Formulation of a drug delivery system based on
a mixture of monoglycerides and triglycerides for use in the treatment of periodontal
disease, J Clin Periodontol 19:687–692, 1992.
Notten F, Koek-van Oosten A, Mikx F: Capillary agar diffusion assay for measuring
metronidazole in human gingival crevicular fluid, Antimicrob Agents Chemother
21:836–837, 1982.
O’Connor BC, Newman HN, Wilson M: Susceptibility and resistance of plaque bacteria
to minocycline, J Periodontol 61:228–233, 1990.
O’Rourke M, Stevens E: Genetic structure of Neisseria gonorrhoeae populations: a
non-clonal pathogen, J Genetic Microbiol 139:2603–2611, 1993.
Olsvik B, Hansen BF, Tenover F, et al: Tetracycline resistant microorganisms recovered
from patients with refractory periodontal disease, J Clin Periodontol 22:391–396, 1995.
Oosterwaal P, Mikx F, Reggli H: Clearance of a topical applied fluorescein gel from
periodontal pockets, J Clin Periodontol 17:613–615, 1990.
Paquette D, Oringer R, Lessem J, et al: Locally delivered minocycline microspheres for
treatment of periodontitis in smokers, J Clin Periodontol 30:787–794, 2003.
Parry MF, Panzer KB, Yukna ME: Quinolone resistance: Susceptibility data from a
300-bed community hospital, Am J Med 87(5A):12S–16S, 1989.
Paton DH, Reeves DS: Clinical features and management of adverse effects of the
quinolone antibacterials, Drug Saf 6:8–27, 1991.
Pavia M, Nobile CGA, Angelillo IF: Meta-analysis of local tetracycline in treating
chronic periodontitis, J Periodontol 74:916–932, 2003.
Payne JB, Stoner JA, Nummikoski PV, et al: Subantimicrobial dose doxycycline effects on
alveolar bone loss in post-menopausal women, J Clin Periodontol 34:776–787, 2007.
Pedrazzoli V, Kilian M, Karring T: Comparative clinical and microbiological effects of
topical subgingival application of metronidazole 25% dental gel and scaling in the
treatment of adult periodontitis, J Clin Periodontol 19:715–722, 1992.
Perinetti G, Paolantonio M, Cordella C, et al: Clinical and microbiological effects
of subgingival administration of two active gels on persistent pockets of chronic
periodontitis patients, J Clin Periodontol 31:282–285, 2004.
Phillips I: Beta-lactamase-producing, penicillin-resistant gonococcus, Lancet 2:656–657,
1976.
Pitcher G, Newman H, Strahan J: Access to subgingival plaque by disclosing agents using
mouthwashes and direct irrigation, J Clin Periodontol 7:300–302, 1980.
Platt R, Dreis MW, Kennedy DL, et al: Serum sickness-like reactions to amoxicillin,
cefaclor, cephalexin and trimethoprim-sulfamethoxazole, J Infect Dis 158:474–477,
1988.
Ploy MC, Grelaud C, Martin C, et al: First clinical isolate of vancomycin-intermediate
Staphylococcus aureus in a French hospital, Lancet 351:1212, 1998.
Preshaw PM, Hefti AF, Novak MJ, et al: Subantimicrobial dose doxycycline enhances the
efficacy of scaling and root planing in chronic periodontitis: A multicenter trial,
J Periodontol 75:1068–1076, 2004.
Preus HR, Lassen J, Aass A, et al: Bacterial resistance following subgingival and systemic
administration of minocycline, J Clin Periodontol 22:380–384, 1995.
Public Health Laboratory Service: Submission to the House of Lords Inquiry, London,
1998, House of Lords.
Pullen H, Wright N, Murdock J, et al: Hypersensitivity reactions to antibacterial drugs in
infectious mononucleosis, Lancet 2:1176, 1967.
Rallison ML, O’Brien J, Good RA: Severe reaction to long acting sulphonamides,
Paediatr 28:908–917, 1961.
Rapley JW, Cobb CM, Killoy WJ, et al: Serum levels of tetracycline during treatment
with tetracycline-containing fibres, J Periodontol 62:817–820, 1992.
Rautelin H, Tee W, Seppälä K, et al: Ribotyping patterns and emergence of metronidazole
resistance in paired clinical samples of Helicobacter pylori, J Antimicrob Chemother
32:1079–1082, 1994.
Ridley AM, Punia P, Ward LR, et al: Plasmid characterization and pulsed-field
electrophoretic analysis demonstrate that ampicillin-resistant strains of Salmonella
enteritidis phage type 6a are derived from Salm. enteritidis phage type 4, J Appl
Bacteriol 81:613–618, 1996.
Rifkin BR, Vernillo AT, Golub LM: Blocking periodontal disease progression by
inhibiting tissue destructive enzymes: a potential role of tetracyclines and their
chemically modified analogues, J Periodontol 64:819–827, 1993.
Riott IM: Hypersensitivity. Riott’s essential immunology, ed 9, Oxford, 1997, Blackwell
Science, 328-352, Ch. 16.
Rodrigues RMJ, Gonçalves C, Souto R, et al: Antibiotic resistance profile of the
subgingival microbiota following systemic or local tetracycline therapy, J Clin
Periodontol 31:420–427, 2004.
Ross BC, Czajkowski L, Vandenberg KL, et al: Characterization of two outer membrane
protein antigens of Porphyromonas gingivalis that are protective in a murine lesion
model, Oral Microbiol Immunol 19:6–15, 2004.
Rowe B, Threlfall EJ: Drug resistance in Gram-negative aerobic bacteria, Br Med Bull
40:68–76, 1984.
Ryan ME, Ramamurthy S, Golub LM: Matrix metalloproteinases and their inhibition in
periodontal treatment, Curr Opin in Periodontol 3:85–96, 1996.
Saglie R, Newman M, Carranza F, et al: Bacterial invasion of gingiva in advanced
periodontitis in humans, J Periodontol 53:217–222, 1982.
Saglie R, Pertuiset J, Rezende M, et al: In situ correlation immuno-identification of
mononuclear cells and invasive bacteria in diseased gingiva, J Periodontol 59:688–696,
1988.
Sanai Y, Persson GR, Starr JR, et al: Presence and antibiotic resistance of Porphyromonas
gingivalis. Prevotella intermedia and Prevotella nigrescens in children, J Clin
Periodontol 29:929–934, 2002.